{"transactions":[{"id":703045,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:10.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":94500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":94500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":94500},"source":{"system":"sec-edgar","filing":"0001994071-26-000006","document":"form4-07272026_040705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000006/form4-07272026_040705.xml","form_type":"4"}},{"id":703044,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:10.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":101287,"source":{"system":"sec-edgar","filing":"0001994071-26-000006","document":"form4-07272026_040705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000006/form4-07272026_040705.xml","form_type":"4"}},{"id":734459,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T21:26:19.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001994071-26-000004","document":"form4-06172026_090615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000004/form4-06172026_090615.xml","form_type":"4"}},{"id":734458,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:26:19.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":18.23,"value":1093800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction report was $18.23, and the range of prices were between $17.95 and $18.66, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":54037,"source":{"system":"sec-edgar","filing":"0001994071-26-000004","document":"form4-06172026_090615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000004/form4-06172026_090615.xml","form_type":"4"}},{"id":734457,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:26:19.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":1.05,"value":63000.0,"ownership":{"direct":true},"balance_after":114037,"source":{"system":"sec-edgar","filing":"0001994071-26-000004","document":"form4-06172026_090615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000004/form4-06172026_090615.xml","form_type":"4"}},{"id":816986,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":39713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":39713},"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816985,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":31848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":60000,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":31848},"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816984,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":1344,"price":22.48,"value":30213.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average purchase price for the transaction report was $22.48, and the range of prices were between $22.45 and $22.56, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":54037,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816983,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":63656,"price":21.91,"value":1394702.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction report was $21.91, and the range of prices were between $21.44 and $22.44, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":55381,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816982,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":39713,"price":1.35,"value":53612.55,"ownership":{"direct":true},"balance_after":119037,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816981,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":31848,"price":1.05,"value":33440.4,"ownership":{"direct":true},"balance_after":79324,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":1078491,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:59:16.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":207000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":207000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":207000},"source":{"system":"sec-edgar","filing":"0001415889-25-020787","document":"form4-07312025_100711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588925020787/form4-07312025_100711.xml","form_type":"4"}},{"id":1401749,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-09-20T23:26:16.000Z","date":"2024-09-19","kind":"exercise","planned":false,"acquired":false,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person's Form 3 filed on October 12, 2023 contains a scrivener's error reflecting an exercise price of $1.06 instead of the correct exercise price of $1.05."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vested on March 24, 2023, and the remaining shares shall vest in 36 monthly installments thereafter."}],"balance_after":91848,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001415889-24-023809","document":"form4-09202024_110913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588924023809/form4-09202024_110913.xml","form_type":"4"}},{"id":1401748,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-20T23:26:16.000Z","date":"2024-09-19","kind":"sale","planned":false,"acquired":false,"shares":14380,"price":16.01,"value":230223.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to sell to cover transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $16.01, and the range of prices were between $15.97 and $16.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":47476,"source":{"system":"sec-edgar","filing":"0001415889-24-023809","document":"form4-09202024_110913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588924023809/form4-09202024_110913.xml","form_type":"4"}},{"id":1401747,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-20T23:26:16.000Z","date":"2024-09-19","kind":"exercise","planned":false,"acquired":true,"shares":42000,"price":1.05,"value":44100.0,"ownership":{"direct":true},"balance_after":61856,"source":{"system":"sec-edgar","filing":"0001415889-24-023809","document":"form4-09202024_110913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588924023809/form4-09202024_110913.xml","form_type":"4"}},{"id":1434986,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & CFO"}}],"security":"Stock option (right to buy)","published_at":"2024-08-13T21:43:57.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":190000,"derivative":{"exercise_price":12.92,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001415889-24-021230","document":"form4-08132024_090853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588924021230/form4-08132024_090853.xml","form_type":"4"}},{"id":1511938,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & CFO"}}],"security":"Stock option (right to buy)","published_at":"2024-05-17T21:11:18.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on May 16, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":30000,"derivative":{"exercise_price":14.4,"expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-24-013577","document":"form4-05172024_090559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588924013577/form4-05172024_090559.xml","form_type":"4"}},{"id":1665391,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, OPERATIONS & INTERIM CFO"}}],"security":"Stock option (right to buy)","published_at":"2024-02-01T01:53:57.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":175000,"derivative":{"exercise_price":16.57,"expiration_date":"2034-01-30","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-24-002121","document":"form4-02012024_010250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588924002121/form4-02012024_010250.xml","form_type":"4"}}]}